Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Alliacense announced today a wave of new MMP™ Portfolio licensees

and also this: An increase in rates of the MMP Licensing Program has ironically reduced the number of shares one can buy for a $1,000.00 !!!!!

Share
New Message
Please login to post a reply